Mikhail Blagosklonny is a science expert. He has done a lot of research on aging and cancer. He is serving currently as a professor at Roswell Park Cancer Institute. He is teaching oncology.
He has done his M.D. as well as PhD from the First Pavlov State Medical University which is in St. Petersburg. This was in cardiology along with experimental medicine. It was in 2002 that he joined New York Medical College. He was an Associate Professor of Medicine here. He moved on to join Ordway Research Institute. He was the senior scientist here. Till 2009 Mikhail Blagosklonny stayed at Ordway. Then he moved on to join the Roswell Park Cancer Institute where he was appointed as their professor of oncology.
He has done various studies in cancer. His research is mainly aimed at targeted cancer therapies. He likes to study about keeping normal cells away from getting damage during chemotherapy or through radioactive rays. He has also done research on the mechanism of aging which is also known as biogerontology. Next, he is doing research on anti-aging treatments too. The other research interests of Mikhail Blagosklonny are cellular and molecular biology along with their clinical investigations. He has done studies in cell cycle, besides anti-cancer therapeutics, as well as cellular senescence, along with signal transduction.
He has studied signal transduction pathways. These tend to lead from cancer to aging. He was able to reveal several potential targets this way that could slow down the process of aging besides various other age-related diseases. Read more about Mikhail at LinkedIn
Mikhail Blagosklonny has deep interest in cancer as well as aging. This is why he has postulated a theory that revolves around the probable role that is played by TOR in cancer and aging. He has proposed that rapamycin can be used in order to extend a person’s life. This drug is presently being used to treat cancer patients.
Mikhail Blagosklonny is the chief writer in oncotarget, besides cell cycle, and aging. He is also the subordinate editor of Cancer Therapy and Biology. Besides, he is the founding editor as well as chief editor of Cancer Research, besides the International Journal of Cancer, as well as Cell Death and Differentiation. Other publications include American Journal of Pathology, along with Autophagy.
Oncotarget refers to a medical journal that is published weekly. It covers research in oncology. It was in 2010 that this journal was launched. Its chief editors are Andrei V. Gudkov along with Mikhail Blagosklonny. Both of them are from Roswell Park Cancer Center. Mikhail Blagosklonny is the writer of over 170 research articles.
It was in 2009 that Mikhail Blagosklonny joined the Roswell Park Cancer Institute. The people here were highly enthusiastic about this appointment as Mikhail Blagosklonny has several invaluable ideas as well as novel approaches for curbing cancer. These ideas include therapy that is tissue-specific therapy. Next is the use of slowing down of aging in order to curb cancer. Visit ResearchGate.Net to learn more about Mikhail’s latest work.
This is an institution that has several modern imaging technologies. These include the optical scanners, besides PET, MRI, along with ultrasound, as well as CT.